hotspot -WSS

hotspot

author：entertainment 2025-09-28 00:52:51 - browse：7427

Adobe

The medical device industry is split on whether a proposed new Medicare reimbursement pathway will do anything to soothe their insurance coverage woes.

Device makers have long complained that the unclear, rocky road to payment kills innovative companies. So they were thrilled when the Trump administration proposed a rule that would have guaranteed four years of Medicare coverage of approved devices deemed “breakthroughs” by the Food and Drug Administration. They hoped private payers would follow suit. But in 2021, under a new administration and a push for more device scrutiny, the Centers for Medicare and Medicaid pulled back on the idea, promising a replacement that would streamline coverage for innovative devices while ensuring safe, high-quality care.

The pathway put forth last week, called Transitional Coverage for Emerging Technologies (TCET), is only a notice, not yet a rule that would grant CMS new powers. The program applies solely to devices that have earned a place in the FDA’s breakthrough device program, which was established to identify devices that the agency believed could provide “more effective” treatment or diagnosis of serious conditions than the current standard of care. But because those devices can be brought to market with less certainty in their benefits and risks than other products, experts said, the idea of automatic reimbursement was dicey.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Eli Lilly’s Mounjaro succeeds in second weight

Wikipedia

WSS

Pharma’s losing bet in New Jersey

Lawsuit challenges CMS nursing home minimum staffing rule

Why we need mandatory labeling of GMO products

The Bio Revolution is changing business and society

Medical students need to learn the potent medicine of empathy

Beyond aggravation: Constipation is an American epidemic

explore

hotspot

hotspot

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Patients, doctors are clashing about side effects of hormonal birth control

As demand for Covid shots wanes, Moderna seeks its next success

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

After affirmative action ruling, medical educators look to 'holistic review'

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

Wildfire smoke exposes gaps in outdoor worker protections

The world needs the new pandemic treaty

Cancer drug shortages should be causing more outrage

Eli Lilly’s Mounjaro succeeds in second weight

knowledge

Decentralized clinical trials need collaboration to achieve wider use

FDA approves first new drug developed for postpartum depression

Biogen nominates mother of director’s child to replace him on board

Why we need mandatory labeling of GMO products

Bispecific antibodies are next new thing in cancer immunotherapy

Eli Lilly’s Mounjaro succeeds in second weight

explore

Wikipedia

explore

hotspot